Roovet Articles

Evidence-based practice

Roovet article quality
Standard article
Last updated Recently · Reviewed through Roovet Articles editorial standards.
Source quality: Strong82 citations detected



no

Evidence-based practice

Evidence-based practice (EBP) is a decision-making approach that integrates the best available research evidence with professional expertise and the preferences, values, and circumstances of the people served. Across medicine, nursing, psychology, education, public health, management, and the social services, **Evidence-based practice** seeks to improve outcomes, reduce unwarranted variation, and de-implement low-value interventions by aligning actions with trustworthy syntheses of evidence and transparent reasoning.[1][2]

In clinical medicine, the term **evidence-based medicine (EBM)** became widely used in the 1990s and is often credited to a group at McMaster University; its core definition emphasises the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients.[3] The same logic underpins **Evidence-based practice** in nursing, allied health, psychology, education, social work and beyond, with discipline-specific frameworks for appraisal and implementation.[4][5]

Evidence-based practice
Triangle linking research evidence, expertise, and patient values
Also called Evidence-informed practice; evidence-based decision-making
Core definition Integrates best research evidence, professional expertise, and client/patient preferences/values to make decisions
Typical steps Ask • Acquire • Appraise • Apply/Act • Assess (the “5 A’s”)
Key outputs Guidelines • Systematic reviews • Recommendations graded by certainty and strength
Common methods Critical appraisal • Meta-analysis • Network meta-analysis • GRADE • Implementation science
Major organizations Cochrane • JBI • NICE • AHRQ • WHO • GRADE Working Group

Concepts and scope

    • Evidence-based practice** is both a philosophy and a set of methods. Its philosophy is pragmatic: decisions should be anchored in the *best available* trustworthy evidence while remaining responsive to context and values. Its methods include formulating answerable questions, searching efficiently, appraising validity and applicability, synthesising findings, translating into recommendations, and evaluating impact.[6]

A widely cited representation is the **EBP triad**: (1) *best research evidence* from systematic research; (2) *expertise*, including clinical skills and contextual knowledge; and (3) *patient/client values and preferences*, including equity, culture, and goals.[7] EBP also recognises constraints (resources, systems, policy) and the need to update decisions as evidence evolves (“living” evidence).

Historical development

Origins and early influences

Measurement, controlled experimentation, and public health evaluation predate the EBP label. 19th-century statisticians and clinicians (e.g., Pierre Louis) promoted numerical methods; 20th-century randomised controlled trials (RCTs) established causal inference for interventions. The modern EBM movement coalesced in the late 20th century at McMaster University and the University of Oxford, emphasising bedside teaching of appraisal skills, structured searches, and summaries for busy clinicians.[8][9]

Infrastructure for synthesis and guidance

The **Cochrane Collaboration** (founded 1993) built methods and infrastructure for rigorous, updatable systematic reviews. National agencies (e.g., AHRQ’s Evidence-based Practice Centers, UK’s NICE) developed guideline processes linking evidence to recommendations with transparent judgments about benefits, harms, values, and resource use. The **GRADE Working Group** (from 2000) standardised how to rate certainty of evidence and strength of recommendations.[10][11][12]

Beyond medicine

Parallel developments occurred across fields: **JBI (Joanna Briggs Institute)** advanced EBP in nursing and allied health; psychology formalised EBP as integration of best research with clinical expertise and client characteristics; education and social policy adopted “what works” centres to link research with practice decisions.[13][14]

Process: the “5 A’s”

Most EBP frameworks articulate a cyclical process, often termed the **5 A’s**:

  1. **Ask** a focused, answerable question (e.g., **PICO(T)** for interventions: *Population*, *Intervention*, *Comparator*, *Outcomes*, *(Timeframe)*; **PEO** for qualitative; **PS** for policy).
  2. **Acquire** the best available evidence efficiently, prioritising pre-appraised sources and systematic reviews.
  3. **Appraise** the validity (risk of bias), consistency, directness, precision, and applicability of the evidence.
  4. **Apply/Act** by integrating evidence with expertise and values, including equity and resource considerations.
  5. **Assess** outcomes and the process, enabling learning cycles and quality improvement.[15]

Formulating questions

Well-constructed questions guide searches and appraisals. Examples include:

  • **Therapy/prevention**: In adults with type 2 diabetes, does GLP-1 therapy versus standard care reduce cardiovascular events over 3 years?
  • **Diagnosis**: In adults with suspected pulmonary embolism, what is the accuracy of age-adjusted D-dimer compared with standard thresholds?
  • **Prognosis**: Among stroke survivors, what is the 1-year risk of recurrent stroke by ABCD2 score?
  • **Qualitative**: How do adolescents describe barriers to accessing mental health services?

Finding the evidence

The search typically moves from **summaries** (guidelines, point-of-care tools), to **syntheses** (systematic reviews, meta-analyses), to **studies** (RCTs, cohort studies, diagnostic accuracy studies) if needed. Efficient searching uses controlled vocabulary (e.g., MeSH), keyword strategies, trial registries, and citation chaining; preprint servers can supplement but require cautious appraisal.[16]

Types of questions and appropriate study designs

Question type Preferred designs (typical) Notes
Intervention (benefits/harms) Randomised controlled trials; pragmatic trials; cluster RCTs; **systematic reviews/meta-analyses** N-of-1 RCTs for individualised decisions; platform/adaptive designs in rapidly evolving areas
Diagnosis Prospective cross-sectional cohorts; case–control for rare diseases; **systematic reviews of accuracy** Use of reference standards; avoid spectrum bias
Prognosis Inception cohorts; registry studies; survival analysis Control for confounders and competing risks
Aetiology/risk Cohort and case–control observational studies; Mendelian randomisation RCTs rarely ethical/feasible for harms
Qualitative Ethnography, grounded theory, phenomenology, qualitative evidence syntheses Explores experiences, acceptability, implementation
Policy/Service Natural experiments; interrupted time series; difference-in-differences Population impact, equity, cost

Critical appraisal: risk of bias and beyond

Appraisal assesses **internal validity** (risk of bias), **precision**, **consistency**, **directness**, **publication bias**, and **applicability**.

  • **Randomised trials** → sequence generation, allocation concealment, blinding, attrition, selective reporting (Cochrane **RoB 2**).[17]
  • **Non-randomised interventions** → confounding, selection, classification of interventions, deviations, missing data, measurement, reporting (ROBINS-I).[18]
  • **Diagnostic accuracy** → patient selection, index test conduct, reference standard, flow/timing (**QUADAS-2**).[19]
  • **Systematic reviews** → protocol adherence, search, selection, bias appraisal, synthesis methods (**AMSTAR 2**).[20]
  • **Observational cohorts/case–control** → representativeness, exposure/outcome ascertainment, control for confounders (e.g., Newcastle–Ottawa Scale).
  • **Qualitative** → credibility, transferability, dependability, confirmability (e.g., JBI critical appraisal tools).[21]

Synthesising evidence

Meta-analysis quantitatively combines effect estimates, with models chosen to reflect heterogeneity (fixed vs. random effects), and explores moderators via subgroup or meta-regression. **Network meta-analysis** compares multiple interventions simultaneously across a network of trials. **Individual participant data (IPD) meta-analyses** re-analyse raw data to harmonise outcomes and covariates. **Living systematic reviews** and **living guidelines** maintain currency in fast-moving fields.[22][23]

From evidence to recommendations: GRADE

The **GRADE** approach rates the **certainty of evidence** (high, moderate, low, very low) for each critical outcome across a body of evidence, considering risk of bias, inconsistency, indirectness, imprecision, and publication bias; it may rate up for large effects, dose–response, or confounding that would reduce effects. GRADE then integrates benefits, harms, values/preferences, resource use, equity, acceptability, and feasibility to issue **strong** or **conditional** recommendations.[24]

Certainty (GRADE) Typical interpretation
High Very confident that the true effect lies close to that of the estimate
Moderate Moderately confident; the true effect is likely close but may be substantially different
Low Limited confidence; the true effect may be substantially different
Very low Very little confidence; the true effect is likely substantially different

Implementation and knowledge translation

Generating trustworthy syntheses is necessary but insufficient; closing the **know–do gap** requires implementation strategies and systems.

  • **Frameworks**: Knowledge-to-Action (KTA) cycle; **CFIR** (Consolidated Framework for Implementation Research); **RE-AIM** (Reach, Effectiveness, Adoption, Implementation, Maintenance).[25][26][27]
  • **Interventions**: clinical decision support (CDS), audit and feedback, academic detailing, reminders, local champions, and co-design with communities.
  • **De-implementation**: identifying and reducing low-value or harmful practices (“Choosing Wisely”), addressing **medical reversal** where new robust evidence contradicts common practice.[28]

EBP across disciplines

Medicine and public health

In health care, EBP informs prevention, screening, diagnosis, treatment, palliation, and systems design. Public health extends EBP to population interventions, balancing internal validity with external validity, feasibility, and equity. **Real-world evidence** from registries and electronic health records complements trials when used with rigorous causal inference methods.[29]

Nursing and allied health

Nursing EBP emphasises patient-centred care, safety, and context of care delivery; models (e.g., JBI, Iowa model) guide bedside implementation, and mixed-methods evidence informs complex interventions and practice environments.[30]

Psychology and mental health

In psychology, EBP incorporates the best available research with clinical expertise in the context of patient characteristics, culture, and preferences; evidence spans RCTs, single-case designs, meta-analyses, and qualitative research relevant to mechanisms and acceptability.[31]

Education and social policy

Evidence-based education evaluates curricula and pedagogies using RCTs, quasi-experiments, and synthesis; social policy employs “what works” centres and **systems thinking** to adapt evidence to diverse communities, with attention to ethics, context, and equity.[32]

Digital EBP and learning health systems

Digital tools compress the **ask–acquire–appraise–apply** cycle: point-of-care summaries, curated evidence feeds, and CDS embedded in electronic records. **Learning health systems** continuously aggregate data from routine care to generate evidence and feed it back into practice; platform and adaptive trials (e.g., for emerging infectious diseases) accelerate learning. As tools incorporate **machine learning and large language models**, key requirements include transparency, calibration, fairness, and evaluation against patient-important outcomes.[33]

Critiques and limitations

EBP has faced vigorous critique, much of which has strengthened methods and broadened scope.

  • **Publication and reporting biases**: selective publication and outcome reporting can distort apparent benefits; preregistration, CONSORT/PRISMA/STROBE, registries, and open data mitigate these risks.[34][35]
  • **Over-reliance on RCTs**: some argue EBP privileges RCTs in ways that undervalue mechanistic reasoning, qualitative evidence, and context; contemporary hierarchies recognise complementary roles and the importance of external validity.[36]
  • **“Cookbook” medicine**: critics worry EBP can reduce care to rules and averages; proponents emphasise that guidelines are **starting points** refined by preferences, equity, multimorbidity, and feasibility.[37]
  • **Industry influence and conflicts of interest**: funding and authorship conflicts can bias design and reporting; modern guideline standards require strict COI management and independent evidence synthesis.[38]
  • **Statistical misuse**: dichotomous p-value thresholds can mislead; emphasis is shifting toward estimation, Bayesian methods, and decision-relevant metrics (absolute risk reductions, NNT/NNH, net benefit).[39]

Methods and tools: a practical map

EBP task Tools and methods Examples/resources
Question formulation PICO/PEO/PS; logic models PICO templates; logic model workshops
Searching Boolean/MeSH; trial registries; citation chasing MEDLINE, EMBASE, CINAHL; ClinicalTrials.gov; WHO ICTRP
Appraisal CASP; Cochrane RoB 2; ROBINS-I; QUADAS-2; AMSTAR 2 Structured checklists; risk-of-bias visualisations
Synthesis Meta-analysis; network meta-analysis; IPD; qualitative syntheses Random-effects models; GOSH/leave-one-out; CERQual
Grading evidence **GRADE** for certainty; EtD frameworks for recommendations Evidence-to-decision (EtD) tables; SoF tables
Implementation CFIR; RE-AIM; KTA; audit & feedback; CDS Guideline implementation toolkits; dashboards
Monitoring/learning Process/outcome measures; QI cycles; real-world data Run charts, SPC; learning health systems

Equity, ethics, and person-centredness

Evidence must be interpreted and applied with **equity and ethics** in mind. Under-representation of groups can limit generalisability; community engagement and pragmatic designs can improve relevance. Person-centred EBP emphasises shared decision-making, health literacy, cultural safety, and respect for autonomy, with attention to **opportunity costs** and **resource stewardship**.[40]

Education and capacity building

EBP education blends didactics (study designs, bias, statistics), hands-on appraisal, and clinical integration through journal clubs, case-based learning, and point-of-care practice. Competencies include formulating questions, efficient searching, risk-of-bias assessment, interpretation of absolute effects, and shared decision-making. Organisations run workshops and online courses, and many journals provide structured abstracts and practice summaries to support learners.[41]

Representative timeline

Year Milestone Significance
1948 MRC streptomycin trial (tuberculosis) Landmark randomised trial
1992 EBM Working Group JAMA editorial Defines a new approach to practice and education
1993 Cochrane Collaboration founded Infrastructure for systematic reviews
1996 Sackett et al. definition in BMJ Triad of evidence, expertise, and values
2000–2004 GRADE Working Group launched Standard for certainty and recommendation strength
2010 CONSORT/PRISMA updates Reporting standards reinforced
2014 “EBM in crisis?” debate Broadens focus to context, person-centredness
2017– Living reviews/guidelines, learning systems Continuous evidence updating

Glossary

**Absolute risk reduction (ARR)**
Difference in event rates between groups; the basis for NNT/NNH.
**Certainty of evidence**
Confidence that an effect estimate reflects the true effect (e.g., GRADE).
**Confidence interval (CI)**
Range of plausible values around an estimate at a given confidence level.
**Implementation science**
Study of methods to promote the uptake of research into practice.
**Meta-analysis**
Statistical pooling of results across studies addressing the same question.
**Network meta-analysis**
Synthesis comparing multiple interventions using direct and indirect evidence.
**N-of-1 trial**
Randomised, multiple-crossover trial in a single participant.
**Publication bias**
Preferential publication of positive or significant findings.
**Risk of bias**
Systematic error in study design, conduct, or reporting that skews results.
**Shared decision-making**
Collaborative choice that integrates evidence with patient preferences and context.

See also

References

  1. ↑ Evidence based medicine: what it is and what it isn't, BMJ, 1996
  2. ↑ Evidence-based medicine. A new approach to teaching the practice of medicine, JAMA, 1992
  3. ↑ Evidence-Based Medicine: How to Practice and Teach EBM (2nd ed.), Churchill Livingstone, 2000
  4. ↑ Evidence-Based Practice in Nursing & Healthcare (4th ed.), Wolters Kluwer, 2018
  5. ↑ Evidence-based practice in psychology, American Psychologist, 2006
  6. ↑ What kind of evidence is it that evidence-based medicine advocates want health care providers and consumers to pay attention to?, BMC Health Services Research, 2002
  7. ↑ Evidence-based medicine: a commentary on common criticisms, CMAJ, 2000
  8. ↑ Evidence-based medicine, ACP Journal Club, 1991
  9. ↑ The science of reviewing research, Annals of the New York Academy of Sciences, 1993
  10. ↑ Cochrane Handbook for Systematic Reviews of Interventions (ver. 6.4), Wiley, 2023
  11. ↑ GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 2008
  12. ↑ GRADE Handbook, The GRADE Working Group, 2013
  13. ↑ The JBI model of evidence-based healthcare, JBI, 2005
  14. ↑ Evidence-based practice in psychology, American Psychologist, 2006
  15. ↑ Evidence-Based Medicine: How to Practice and Teach EBM (4th ed.), Churchill Livingstone, 2010
  16. ↑ PICO, PICOS and SPIDER: metacognition and the search for answers, Health Information and Libraries Journal, 2016
  17. ↑ RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 2019
  18. ↑ ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 2016
  19. ↑ QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies, Annals of Internal Medicine, 2011
  20. ↑ AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, BMJ, 2017
  21. ↑ Qualitative research synthesis, JBI Reviewer's Manual, 2015
  22. ↑ Indirect and mixed-treatment comparison, network, or multiple treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool, Research Synthesis Methods, 2012
  23. ↑ Living systematic review: 1. Introduction—the why, what, when, and how, Journal of Clinical Epidemiology, 2017
  24. ↑ GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables, Journal of Clinical Epidemiology, 2011
  25. ↑ Lost in knowledge translation: time for a map?, Journal of Continuing Education in the Health Professions, 2006
  26. ↑ Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science, Implementation Science, 2009
  27. ↑ Evaluating the public health impact of health promotion interventions: the RE-AIM framework, American Journal of Public Health, 1999
  28. ↑ Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices, Implementation Science, 2014
  29. ↑ Real-world evidence — what is it and what can it tell us?, New England Journal of Medicine, 2016
  30. ↑ The Iowa Model of Evidence-Based Practice to Promote Quality Care, University of Iowa, 2018
  31. ↑ Evidence-based practice in psychology, American Psychologist, 2006
  32. ↑ Evidence-Based Policy: A Practical Guide to Doing It Better, Oxford University Press, 2012
  33. ↑ Toward a science of learning systems: a research agenda for the high-functioning Learning Health System, Journal of the American Medical Informatics Association, 2010
  34. ↑ Why most published research findings are false, PLoS Medicine, 2005
  35. ↑ The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 2021
  36. ↑ Evolution of evidence hierarchies: what can it mean for the cochrane collaboration?, Journal of Clinical Epidemiology, 2016
  37. ↑ Evidence based medicine: a movement in crisis?, BMJ, 2014
  38. ↑ Guideline development methodology, Annals of Internal Medicine, 2009
  39. ↑ The ASA’s statement on p-values: context, process, and purpose, The American Statistician, 2016
  40. ↑ The optimal practice of evidence-based medicine: Incorporating patient preferences in practice guidelines, JAMA, 2017
  41. ↑ Teaching basic science to optimize transfer, Advances in Health Sciences Education, 2004

Further reading

  • How to Read a Paper: The Basics of Evidence-Based Medicine and Healthcare (6th ed.), Wiley-Blackwell, 2019
  • Evidence-Based Practice Workbook (2nd ed.), BMJ Books, 2007
  • Users' Guides to the Medical Literature (3rd ed.), McGraw–Hill, 2015
  • Avoidable waste in the production and reporting of research evidence, The Lancet, 2009
  • CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, BMJ, 2010
  • The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement, PLoS Medicine, 2007
  • Mixed methods and systematic reviews, International Journal of Social Research Methodology, 2010
  • Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise, CMAJ, 2019

External links

Article tools

Use and verify this page

Suggest correction
Page information Metadata, revision, and page details View history Full revision history Permanent link Stable link to this revision What links here Pages linking to this article Related changes Recent edits on linked pages Printable version Reader-friendly print view
Cite this page Evidence-based practice. Roovet Articles. Retrieved from https://articles.roovet.com/Evidence-based_practice
Explore more

Related articles

Random article
Open science Mentioned in this article Psychology Links to this article Abnormal psychology Links to this article Hip hop music Shared topic Citigroup Shared topic Chaebol Shared topic ISBN (identifier) Shared topic Nasdaq Shared topic
Share: X Facebook LinkedIn Reddit WhatsApp Telegram Email